The Aryl Hydrocarbon Receptor Is Expressed in Thyroid Carcinoma and Appears to Mediate Epithelial-Mesenchymal-Transition
Aryl hydrocarbon receptor (AhR) is expected to promote initiation, progression and invasion of cancer cells regulating proliferation, differentiation, gene expression, inflammation, cell motility and migration. Furthermore, an immunosuppressant function of AhR has been recognized. This study evaluat...
Main Authors: | Sonia Moretti, Nicole Nucci, Elisa Menicali, Silvia Morelli, Vittorio Bini, Renato Colella, Martina Mandarano, Angelo Sidoni, Efisio Puxeddu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/1/145 |
Similar Items
-
Epithelial-Mesenchymal Transition Proteins in Neuroendocrine Neoplasms: Differential Immunohistochemical Expression in Different Sites and Correlation with Clinico-Pathological Features
by: Elia Guadagno, et al.
Published: (2020-05-01) -
Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer
by: Cinzia Antognelli, et al.
Published: (2019-06-01) -
Role of aryl hydrocarbon receptors in infection and inflammation
by: Linglan Xu, et al.
Published: (2024-04-01) -
The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases
by: Drew R. Neavin, et al.
Published: (2018-12-01) -
Aryl Hydrocarbon Receptor (AHR) Ligands as Selective AHR Modulators (SAhRMs)
by: Stephen Safe, et al.
Published: (2020-09-01)